141 related articles for article (PubMed ID: 31130393)
21. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
22. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.
Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H
Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for increased antimicrobial resistance: a retrospective analysis of 309 acute cholangitis episodes.
Schneider J; De Waha P; Hapfelmeier A; Feihl S; Römmler F; Schlag C; Algül H; Schmid RM; Wantia N; Huber W; Weber A
J Antimicrob Chemother; 2014 Feb; 69(2):519-25. PubMed ID: 24084640
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic/Pharmacodynamic Index Linked to
Jimenez-Toro I; Rodriguez CA; Zuluaga AF; Otalvaro JD; Perez-Madrid H; Vesga O
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0096622. PubMed ID: 36695584
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study.
Biedenbach DJ; Iaconis JP; Sahm DF
J Antimicrob Chemother; 2016 Dec; 71(12):3459-3464. PubMed ID: 27559120
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
[TBL] [Abstract][Full Text] [Related]
27. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics.
Kitamura Y; Yoshida K; Kusama M; Sugiyama Y
Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846
[TBL] [Abstract][Full Text] [Related]
28. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center.
Salvador VB; Lozada MC; Consunji RJ
Surg Infect (Larchmt); 2011 Apr; 12(2):105-11. PubMed ID: 21348769
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.
Iida S; Kinoshita H; Kawanishi T; Hayashi M
Eur J Drug Metab Pharmacokinet; 2009; 34(2):107-15. PubMed ID: 19645220
[TBL] [Abstract][Full Text] [Related]
31. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.
Fish DN; Kiser TH
Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of the Tokyo Guidelines 2013 for severity assessment of acute cholangitis.
Nishino T; Hamano T; Mitsunaga Y; Shirato I; Shirato M; Tagata T; Shimada M; Yoshida S; Mitsunaga A
J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):841-9. PubMed ID: 25410528
[TBL] [Abstract][Full Text] [Related]
33. Bile Culture May Guide Antibiotic Stewardship in Acute Bacterial Cholangitis.
George JT; Thomas A; Jaleel R; Paul GJS; John A; Kurien RT; Chowdhury SD; Simon EG; Joseph AJ; Dutta AK
Dig Dis Sci; 2024 May; 69(5):1872-1879. PubMed ID: 38457116
[TBL] [Abstract][Full Text] [Related]
34. Urgent ERCP for acute cholangitis reduces mortality and hospital stay in elderly and very elderly patients.
Park CS; Jeong HS; Kim KB; Han JH; Chae HB; Youn SJ; Park SM
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):619-625. PubMed ID: 27919851
[TBL] [Abstract][Full Text] [Related]
35. Bacteriology and antimicrobial choice in hepatolithiasis.
Sheen-Chen S; Chen W; Eng H; Sheen C; Chou F; Cheng Y; Lee T
Am J Infect Control; 2000 Aug; 28(4):298-301. PubMed ID: 10926707
[TBL] [Abstract][Full Text] [Related]
36. Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis.
Karpel E; Madej A; Bułdak Ł; Duława-Bułdak A; Nowakowska-Duława E; Łabuzek K; Haberka M; Stojko R; Okopień B
Scand J Gastroenterol; 2011 Jul; 46(7-8):925-30. PubMed ID: 21504380
[TBL] [Abstract][Full Text] [Related]
37. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
[TBL] [Abstract][Full Text] [Related]
38. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.
Stass H; Dalhoff A
Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709
[TBL] [Abstract][Full Text] [Related]
39. Infections of the biliary tract.
Kochar R; Banerjee S
Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):199-218. PubMed ID: 23540957
[TBL] [Abstract][Full Text] [Related]
40. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
